In contrast, overexpression of G6PC affects glucose metabolism in ovarian (56), glioblastoma (57), and cervical cancer (58), contributing to tumor proliferation, metastasis, and poor prognosis in patients. The gene discussed is G6PC1; the disease is glioblastoma.